HRCM
TEVA icon

Hawk Ridge Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Hawk Ridge Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,520,353
Closed -$24.7M – 62
2024
Q2 		$24.7M Buy
+1,520,353
New +$23.4M 1.06% 32

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Hawk Ridge Capital Management's TEVA Position: Q3 2024 in Review

Hawk Ridge Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2024, closing a stake of 1,520,353 shares — an estimated $24.7M sold.

Hawk Ridge Capital Management first reported a position in TEVA in Q2 2024 and held it in 1 quarter. The position peaked at $24.7M in Q2 2024. 543 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Hawk Ridge Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2024 after selling out during the quarter.
  • Hawk Ridge Capital Management sold 1,520,353 Teva Pharmaceutical Industries Limited shares in Q3 2024, an estimated $24.7M.
  • Hawk Ridge Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and held it in 1 quarter.
  • Hawk Ridge Capital Management's Teva Pharmaceutical Industries Limited position peaked at $24.7M in Q2 2024.
  • 543 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2024.

Based on Hawk Ridge Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.